Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. FBT: which is better?

Bottom line

BBH vs FBT: the short answer

BBH (VanEck Biotech ETF) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are quite different portfolios: only about 36% of their top holdings (by weight) are shared.

BBH is cheaper at 0.35% vs 0.55% — a difference of $20 a year per $10,000 invested.

Over five years, FBT returned +4.3% a year vs +2.7% for BBH.

Updated Nov 19, 2026

BBH vs FBT side by side

BBHFBT
TypeETFETF
Fund familyVanEckFirst Trust
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.55%
Annual cost per $10k$35$55
10-yr cost on $10k (prospectus)$443—
Max front loadNoneNone
12b-1 fee—0%
1-yr return+21.2%+24.1%
5-yr return (annualized)+2.7%+4.3%
10-yr return (annualized)+4.5%+6.3%
Best quarter+27.6%+27.8%
Worst quarter−18.2%−22.5%
Net assets (fund)$395.6M$2.8B
Number of holdings2532
Portfolio turnover19%37%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHFBTDifference
2025+21.2%+24.1%−2.9%
2024−4.4%+5.8%−10.1%
2023+3.9%+2.3%+1.6%
2022−15.1%−4.6%−10.5%
2021+11.8%−3.6%+15.4%
2020+22.1%+12.9%+9.1%
2019+25.8%+19.8%+6.0%
2018−10.2%−0.2%−10.0%
2017+16.6%+37.0%−20.4%
2016−15.0%−19.6%+4.6%

Source: Fund prospectus bar charts

Holdings overlap

13 of BBH's top 25 holdings also appear in FBT's top 25.

Shared top holdings
HoldingBBHFBT
Amgen Inc15.25%2.78%
Vertex Pharmaceuticals Inc9.10%3.07%
Argenx SE4.97%3.13%
Natera Inc4.92%3.79%
Alnylam Pharmaceuticals Inc3.83%2.52%
Biogen Inc3.63%3.37%
Illumina Inc3.17%3.92%
United Therapeutics Corp2.83%2.56%
Incyte Corp2.49%3.18%
Neurocrine Biosciences Inc2.08%3.53%
BioNTech SE1.94%2.63%
Bio-Techne Corp1.54%3.43%
BioMarin Pharmaceutical Inc1.34%2.83%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

FBT top 10

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Illumina Inc — 3.92%
  7. Krystal Biotech Inc — 3.87%
  8. Natera Inc — 3.79%
  9. Axsome Therapeutics Inc — 3.71%
  10. Neurocrine Biosciences Inc — 3.53%

FAQ

What is the difference between BBH and FBT?
BBH (VanEck Biotech ETF) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are quite different portfolios: only about 36% of their top holdings (by weight) are shared. BBH is cheaper at 0.35% vs 0.55% — a difference of $20 a year per $10,000 invested.
Which is cheaper, BBH or FBT?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and FBT?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.